SOLUTIONS PRODUCTS INNOVATION INVESTORS ESG
0
Add to list
GB COVID-19 Ag POCT
Cat. No. 4ECO101E
More details>
(3 items)
SOLUTIONS PRODUCTS INNOVATION INVESTORS ESG About GBC Our Brands R&D Media Join us Contact us
English 繁體中文
IVD Solutions
Menu
HEPAVASE A-96 (TMB) (Anti-HAV Antibody)
Competitive ELISA for detecting Anti-HAV antibodies in serum/plasma. 99.8% sensitivity, 99.5% specificity; only 10 µL sample, 150-minute assay. TFDA certified.
USEFUL RESOURCES
Add to List
>  PRODUCT DESCRIPTION>  SPECIFICATION>  PERFORMANCE>  ORDERING INFORMATION
PRODUCT DESCRIPTION
This product is a competitive ELISA reagent designed for qualitative detection of Anti-HAV antibodies in human serum or plasma. With a 10 µL sample volume, 450 nm read wavelength, and 150-minute incubation time, it ensures sensitive and specific results (99.8% sensitivity, 99.5% specificity) with Inter-assay CV <25% and Intra-assay CV <20%. Certified by TFDA, it is reliable, user-friendly, and suited for clinical laboratory use.
SPECIFICATION
Number of wells96
PrincipleCompetitive
Assay formatQualitative
Total incubation time150 minutes
Sample typeSerum / Plasma
Sample volume10 μL
Reading wavelength450nm
Storage2-8°C
CertificationTFDA
PERFORMANCE

1541 hospitalized patients were tested. The results are as follows:

PERFORMANCETest PositiveTest Negative
Confirmed Positive5511
Confirmed Negative5984
Inter-assay precision CV< 25%Intra-assay precision CV< 20%

The diagnostic sensitivity is 99.8%;The diagnostic specificity is 99.5%

ORDERING INFORMATION
Catalogue No.Product
4AGE3GB HEPAVASE A-96 (TMB)